Restriction of clindamycin lowers Clostridium difficile infection rates

0

“Clindamycin was reduced 92.61% without an increase in other antibiotics. We identified high consumption of clindamycin as a risk factor for CDI.” Cruz-Rodríguez et al (2014).

Reference:

Cruz-Rodríguez, N.C., Hernández-García, R., Salinas-Caballero, A.G., Pérez-Rodríguez, E., Garza-González, E. and Camacho-Ortiz, A. (2014) The effect of pharmacy restriction of clindamycin on Clostridium difficile infection rates in an orthopedics ward. AJIC: American Journal of Infection Control. 42(6), p.e71-e73.

Abstract:

A high consumption of clindamycin was noted in an orthopedics ward with high rates of Clostridium difficile infection (CDI). We restricted clindamycin for the entire ward. A reduction of 88% in CDI (1.07 to 0.12 × 1,000 patients-days, P = .056) and 84% for all-cause diarrhea (2.40 to 0.38 × 1,000 patients-days, P = .021) was achieved. Clindamycin was reduced 92.61% without an increase in other antibiotics. We identified high consumption of clindamycin as a risk factor for CDI.

Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).

Main page

Share.

Comments are closed.

Free Email Updates
Join 5.5K IVTEAM members. Subscribe now and be the first to receive all the latest free updates from IVTEAM!
100% Privacy. We don't spam.